Analyst Arthur Wong explores the potential mixed credit implications the Donald Trump presidential election win may hold for the pharmaceutical industry.

The S&P Pharma Dose – Episode 9: Pharma and Trump

S&P Global Ratings Podcast. Tune in for S&P Global Ratings analysts' opinions on trends and events that affect the global markets and your investment decisions. Download the S&P Global Ratings' Podcast to any portable audio device or your desktop. Make the most of your time and stay on top of important business developments around the world. Listen in! Our CreditMatters videos and podcasts provide an easy and informative way to keep up with S&P Global Ratings' global perspective on important credit market developments anytime, anywhere.

Business

S&amp;P Global Ratings Podcast. Tune in for S&amp;P Global Ratings analysts' opinions on trends and events that affect the global markets and your investment decisions. Download the S&amp;P Global Ratings' Podcast to any portable audio device or your desktop. Make the most of your time and stay on top of important business developments around the world. Listen in! Our CreditMatters videos and podcasts provide an easy and informative way to keep up with S&amp;P Global Ratings' global perspective on important credit market developments anytime, anywhere.

Share The S&P Pharma Dose – Episode 9: Pharma and Trump

Sign up to save your podcasts

The S&P Pharma Dose – Episode 9: Pharma and Trump

The S&P Pharma Dose – Episode 9: Pharma and Trump